EP4384222A4 - Go-2-me- und rgo-2-me-hybride, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Go-2-me- und rgo-2-me-hybride, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
EP4384222A4
EP4384222A4 EP22856321.9A EP22856321A EP4384222A4 EP 4384222 A4 EP4384222 A4 EP 4384222A4 EP 22856321 A EP22856321 A EP 22856321A EP 4384222 A4 EP4384222 A4 EP 4384222A4
Authority
EP
European Patent Office
Prior art keywords
rgo
hybrids
production
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22856321.9A
Other languages
English (en)
French (fr)
Other versions
EP4384222A1 (de
Inventor
Magdalena Gorska-Ponikowska
Ludwika Lipinska
Joanna Gieraltowska
Magdalena Baran
Adrian Chlanda
Krystian Kowiorski
Lucyna Konieczna
Mariusz Belka
Anna Kamm
Alicja Kuban-Jankowska
Jacek Gulczynski
Ewa Izycka-Swieszewska
Narcyz Knap
Aleksander Zolnierski
Tomasz Baczek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Uniwersity of Gdansk
Siec Badawcza Lukasiewicz Instytut Mikroelektroniki i Fotoniki
Original Assignee
Medical Uniwersity of Gdansk
Siec Badawcza Lukasiewicz Instytut Mikroelektroniki i Fotoniki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Uniwersity of Gdansk, Siec Badawcza Lukasiewicz Instytut Mikroelektroniki i Fotoniki filed Critical Medical Uniwersity of Gdansk
Publication of EP4384222A1 publication Critical patent/EP4384222A1/de
Publication of EP4384222A4 publication Critical patent/EP4384222A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Ceramic Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP22856321.9A 2021-08-13 2022-08-12 Go-2-me- und rgo-2-me-hybride, verfahren zu ihrer herstellung und ihre verwendung Pending EP4384222A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL438737A PL243445B1 (pl) 2021-08-13 2021-08-13 Hybrydy GO-2-ME i rGO 2-ME, sposób ich otrzymywania oraz zastosowanie
PCT/PL2022/050050 WO2023018342A1 (en) 2021-08-13 2022-08-12 Go-2-me and rgo 2-me hybrids, the method of obtaining them, and their application

Publications (2)

Publication Number Publication Date
EP4384222A1 EP4384222A1 (de) 2024-06-19
EP4384222A4 true EP4384222A4 (de) 2026-05-20

Family

ID=85200946

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22856321.9A Pending EP4384222A4 (de) 2021-08-13 2022-08-12 Go-2-me- und rgo-2-me-hybride, verfahren zu ihrer herstellung und ihre verwendung

Country Status (3)

Country Link
EP (1) EP4384222A4 (de)
PL (1) PL243445B1 (de)
WO (1) WO2023018342A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL449413A1 (pl) * 2024-07-30 2026-02-02 Gdański Uniwersytet Medyczny Kompozycja farmaceutyczna, preparat zawierający kompozycję farmaceutyczną i ich zastosowanie w leczeniu nowotworów skóry
PL450037A1 (pl) * 2024-10-15 2026-04-20 Wojskowa Akademia Techniczna Im. Jarosława Dąbrowskiego Zawiesina tlenku grafenu do podawania w postaci aerozolu i jej zastosowanie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2532449A (en) * 2014-11-19 2016-05-25 Univ Manchester Use of Nanomaterials in treating cancer

Also Published As

Publication number Publication date
PL438737A1 (pl) 2023-02-20
PL243445B1 (pl) 2023-08-28
WO2023018342A1 (en) 2023-02-16
EP4384222A1 (de) 2024-06-19

Similar Documents

Publication Publication Date Title
EP3854877A4 (de) Modifizierte t-zelle, verfahren zu ihrer herstellung und ihre verwendung
EP4245873C0 (de) Kriechfeste, langlebige, nickelbasierte verformungssuperlegierung und verfahren zu ihrer herstellung und verwendung
EP4019121A4 (de) Supernasse oberfläche und verfahren zu ihrer herstellung und ihre verwendung
EP4018501A4 (de) Ionenleitende strukturen, vorrichtungen mit ionenleitenden strukturen sowie verfahren zu ihrer verwendung und herstellung
EP4365967C0 (de) Solarzelle und verfahren zu ihrer herstellung
EP4039803A4 (de) Gentechnisch veränderte menschliche immunzellen, verfahren zu ihrer herstellung und ihre verwendung
EP2410926A4 (de) Ballonausgabevorrichtung sowie verfahren zu ihrer herstellung und verwendung
EP3954694A4 (de) Ubiquitin-spezifische proteaseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung
EP3936495C0 (de) Gaserzeugende mittelzusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
EP3858818A4 (de) Triketonverbindung, verfahren zu ihrer herstellung und ihre verwendung sowie herbizid
EP3936504A4 (de) Pyrazolo[1,5-a]pyridinderivate, verfahren zu ihrer herstellung und ihre verwendung
EP4097155C0 (de) Aktinisch vernetzbare polysiloxan-polyglycerin-blockcopolymere, verfahren zu ihrer herstellung und ihre verwendung
EP4047113A4 (de) Polyamid-inselfaser, verfahren zu ihrer herstellung und ihre verwendung
EP4037003A4 (de) Asynchrone heiz- und kalendriervorrichtung, grosse breite ultradünne lithiummetallfolie, verfahren zu ihrer herstellung und ihre verwendung
EP4039687A4 (de) Tetracyclische pyrimidinonverbindung, verfahren zu ihrer herstellung, zusammensetzung und ihre verwendung
EP4150240C0 (de) Schlauchanordnung und verfahren zu ihrer herstellung und verwendung
EP4039799A4 (de) Manipulierte immunkillerzelle, verfahren zu ihrer herstellung und ihre verwendung
ATE509923T1 (de) Derivate von 7-alkynyl-1,8-naphthyridonen, verfahren zu ihrer herstellung und ihre verwendung in therapeutika
ATE517092T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
EP4022104A4 (de) Magnesiumlegierungsbasierte gegenstände und verfahren zu ihrer herstellung und ihre verwendung
EP3929180C0 (de) Chinolincarbonsäureesterverbindung und verfahren zu ihrer herstellung sowie ihre verwendung
EP4015625A4 (de) Universelle car-t-zelle und verfahren zu ihrer herstellung und verwendung
EP3929181A4 (de) 6-oxo-1,6-dihydropyridazin-prodrug-derivate, verfahren zu ihrer herstellung und ihre verwendung in der medizin
EP4033912A4 (de) Titandioxidfreie weissfilmbeschichtungszusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
EP4401780A4 (de) Amorphe photosensibilisierende teilchen, verfahren zu ihrer herstellung und verfahren zu ihrer verwendung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0047520000

Ipc: A61K0047690000